Real‐World Use, Effectiveness and Tolerability of Antidepressant Treatment in Oncology Patients
Antidepressants were equally effective in treating depression among cancer patients. Vortioxetine emerged as a well-tolerated and preferred option for chemotherapy patients. These findings emphasize the importance of tolerability and drug-interaction profiles in oncology care.
Authors
- Delfina Janiri (ORCID: https://orcid.org/0000-0003-2485-6121)
- Giovanni Camardese (ORCID: https://orcid.org/0000-0002-8139-9230)
- Antonio Maria D’Onofrio (ORCID: https://orcid.org/0009-0007-6807-5796)
- Antonio Restaino (ORCID: https://orcid.org/0009-0008-1264-0167)
- Silvia Montanari (ORCID: https://orcid.org/0009-0007-0266-0204)
- Alessio Simonetti (ORCID: https://orcid.org/0000-0002-6963-7494)
- Gabriele Sani (ORCID: https://orcid.org/0000-0002-9767-8752)
- Flavia Grisoni (ORCID: https://orcid.org/0009-0004-6508-3721)
- Alexia E. Koukopoulos (ORCID: https://orcid.org/0000-0002-7004-5007)
- Claudia Calderoni (ORCID: https://orcid.org/0009-0009-9046-1751)
Institutions
- Università Cattolica del Sacro Cuore (IT)
- Baylor College of Medicine (US)
- Agostino Gemelli University Polyclinic (IT)
- Link Campus University (IT)
Publication Details
- Journal
- Psycho-Oncology
- Published
- 2025-11-30
- DOI
- https://doi.org/10.1002/pon.70340
- Primary Topic
- Cancer survivorship and care
- Type
- article
- Field-Weighted Citation Impact
- 0.00